Back to mobile site

UBS Reiterates Buy Rating on Inspire Medical Systems (INSP)

February 11, 2025 9:40 AM EST Send to a Friend
UBS analyst Danielle Antalffy reiterated a Buy rating and $265.00 price target on Inspire Medical Systems (NYSE: INSP).She said, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login